Lyell Immunopharma (LYEL) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-3.6
-2.46
-1.31
-0.17

Details

Expected EPS
-3.52
Actual EPS
-2.89
Surprise EPS
0.63
Surprise Percent
+17.9%

Description

Lyell Immunopharma (LYEL) has reported earnings of -2.89 per share for Q3 2025.

0 Comments

Share your thoughts